News
SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today ...
WASHINGTON, DC – Dr. Vinay Prasad has been reinstated to a senior position at the Food and Drug Administration, according to ...
With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...
The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration.Prasad had previously overruled his own scientific review ...
7h
TipRanks on MSNQuince Therapeutics Reports Q2 2025 Financial Results
Quince Therapeutics ( ($QNCX) ) has released its Q2 earnings. Here is a breakdown of the information Quince Therapeutics presented to its ...
15h
Medpage Today on MSNOusted FDA Vaccine Chief Vinay Prasad Is Returning to the Agency
Vinay Prasad, MD, MPH, is resuming leadership of the FDA center that regulates vaccines and biotech therapies, an HHS ...
An FDA official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results